×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OPRX – optimizerx corporation (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
07:26 am
oprx
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/17
05:38 am
oprx
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]
Medium
Report
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]
12/17
04:30 am
oprx
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
Medium
Report
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
12/14
01:26 am
oprx
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Wall Street Zen
Low
Report
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Wall Street Zen
12/10
08:36 am
oprx
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift [Yahoo! Finance]
Low
Report
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift [Yahoo! Finance]
12/10
04:10 am
oprx
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
11/26
12:30 am
oprx
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
Low
Report
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
11/18
01:18 pm
oprx
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/15
07:47 pm
oprx
Form 4 OptimizeRx Corp For: Dec 11 Filed by: Merrell Brendan W.
Medium
Report
Form 4 OptimizeRx Corp For: Dec 11 Filed by: Merrell Brendan W.
12/15
07:43 pm
oprx
Form 4 OptimizeRx Corp For: Dec 11 Filed by: D'Silva Andrew J.
Medium
Report
Form 4 OptimizeRx Corp For: Dec 11 Filed by: D'Silva Andrew J.
11/10
09:56 am
oprx
Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.
Medium
Report
Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.
11/10
09:55 am
oprx
Form 3 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.
Medium
Report
Form 3 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W.
11/7
05:51 pm
oprx
Form 4 OptimizeRx Corp For: Oct 01 Filed by: D'Silva Andrew J.
Medium
Report
Form 4 OptimizeRx Corp For: Oct 01 Filed by: D'Silva Andrew J.
11/7
04:03 pm
oprx
Form 10-Q OptimizeRx Corp For: Sep 30
Medium
Report
Form 10-Q OptimizeRx Corp For: Sep 30
11/6
04:15 pm
oprx
Form 8-K OptimizeRx Corp For: Nov 06
High
Report
Form 8-K OptimizeRx Corp For: Nov 06
11/3
08:13 pm
oprx
Form 4 OptimizeRx Corp For: Nov 01 Filed by: Greco Theresa
Medium
Report
Form 4 OptimizeRx Corp For: Nov 01 Filed by: Greco Theresa
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form NT 10-K OptimizeRx Corp For: Dec 31
31.9%
12/9 OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook 16.4%
5/8 Q1/2019 3/31/2019 EPS 0.060 ZacksConsensus -0.010 ActVsEst 0.070 - Beat 15.6%
1/29 OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform 13.2%
3/6 Form 8-K OptimizeRx Corp For: Mar 05 8.8%
4/16 OptimizeRx Sets First Quarter 2020 Conference Call for Monday, May 4, 2020 at 4:30 p.m. ET 8.7%
8/7 Q2/2019 6/30/2019 EPS 0.090 ZacksConsensus 0.030 ActVsEst 0.060 - Beat 8.4%
5/14 OptimizeRx Co. (NASDAQ: OPRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $16.00 price target on the stock. 6.9%
3/12 Form 8-K OptimizeRx Corp For: Mar 11 6.8%
3/10 OptimizeRx Launches ‘Digital Healthcare’ Webinar Series 5.8%
12/9 OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook 16.4%
5/8 Q1/2019 3/31/2019 EPS 0.060 ZacksConsensus -0.010 ActVsEst 0.070 - Beat 15.6%
1/29 OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform 13.2%
3/6 Form 8-K OptimizeRx Corp For: Mar 05 8.8%
4/16 OptimizeRx Sets First Quarter 2020 Conference Call for Monday, May 4, 2020 at 4:30 p.m. ET 8.7%
8/7 Q2/2019 6/30/2019 EPS 0.090 ZacksConsensus 0.030 ActVsEst 0.060 - Beat 8.4%
5/14 OptimizeRx Co. (NASDAQ: OPRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $16.00 price target on the stock. 6.9%
3/12 Form 8-K OptimizeRx Corp For: Mar 11 6.8%
3/10 OptimizeRx Launches ‘Digital Healthcare’ Webinar Series 5.8%
TOP News Decliners
4/17
OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.
-27.7%
2/28 Form 8-K OptimizeRx Corp For: Feb 27 -18.5%
3/18 OptimizeRx to Host Online Session with Clinical Leaders at Microsoft, Massachusetts General Hospital and BD -15.7%
11/5 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus 0.060 ActVsEst (0.110) - Miss -13.8%
3/26 Form 10-K OptimizeRx Corp For: Dec 31 -9.6%
3/9 OptimizeRx Digital Health Network Now Delivering CDC Coronavirus Alerts to Thousands of Healthcare Providers Nationwide -9.0%
3/13 Form 4 OptimizeRx Corp For: Mar 11 Filed by: BAKER DOUGLAS P -7.6%
1/18 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.7%
11/5 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -4.4%
8/9 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.7%
2/28 Form 8-K OptimizeRx Corp For: Feb 27 -18.5%
3/18 OptimizeRx to Host Online Session with Clinical Leaders at Microsoft, Massachusetts General Hospital and BD -15.7%
11/5 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus 0.060 ActVsEst (0.110) - Miss -13.8%
3/26 Form 10-K OptimizeRx Corp For: Dec 31 -9.6%
3/9 OptimizeRx Digital Health Network Now Delivering CDC Coronavirus Alerts to Thousands of Healthcare Providers Nationwide -9.0%
3/13 Form 4 OptimizeRx Corp For: Mar 11 Filed by: BAKER DOUGLAS P -7.6%
1/18 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.7%
11/5 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -4.4%
8/9 OptimizeRx Co. (NASDAQ: OPRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: